BYDUREON
- Product NDC
- 0310-6530
- 11-digit product format
- 003106530
- Labeler code
- 0310
- Product ID
- 0310-6530_c9d94096-3a71-4708-97e1-ae0b9a31c681
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- exenatide
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- SUBCUTANEOUS
- Labeler
- AstraZeneca Pharmaceuticals LP
- Application
- NDA022200
- Marketing category
- NDA
- Marketing start
- 2014-09-08
- Marketing end
- 2023-04-30
- Substance
- EXENATIDE
- Active strength
- 2 mg/.65mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0310-6530-01 | 00310653001 | 1 CARTRIDGE in 1 TRAY (0310-6530-01) > .65 mL in 1 CARTRIDGE | 1 cartridge | 2014-09-08 | 0000-00-00 | No | No | Current |
| 0310-6530-04 | 00310653004 | 1 TRAY in 1 CARTON (0310-6530-04) > 4 CARTRIDGE in 1 TRAY > .65 mL in 1 CARTRIDGE | 1 tray | 2014-09-08 | 0000-00-00 | No | No | Current |